Back to Journals » Cancer Management and Research » Volume 12

Anlotinib Exerts Anti-Cancer Effects on KRAS-Mutated Lung Cancer Cell Through Suppressing the MEK/ERK Pathway

Total article views   HTML views PDF downloads Totals
8,909 Dovepress* 8,192+ 1,009 9,201
PubMed Central* 717 267 984
Totals 8,909 1,276 10,185
*Since 19 May 2020
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 1 4

View citations on PubMed Central and Google Scholar